Overhyped? Digital Health Executive Anti-Predictions For Healthcare In 2024
Will General Catalyst’s plans for health system acquisition come to fruition in 2024? Will GenAI live up to its hype as healthcare’s ultimate complexity liberator?
Stay updated with breaking news from Hal Andrews. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Will General Catalyst’s plans for health system acquisition come to fruition in 2024? Will GenAI live up to its hype as healthcare’s ultimate complexity liberator?
Trilliant Health, the healthcare industry’s leading analytics firm, today released its Market Explorer…
AbbVie announced plans to acquire Immunogen — and the biotech’s recently approved ADC treatment for ovarian cancer — for $10.1 billion in cash. The pharma giant is diving into ADCs again after a previous multibillion-dollar acquisition of a different ADC drugmaker ended up failing a few years ago.
The directory contains information on more than 2.7 million providers nationwide with over 65 million data points.
Administration officials are expected to unveil the list<b> </b>before stock markets open Tuesday since it could affect public drug companies’ stock prices.